CERT · Certara, Inc. · Executive Compensation
$9.23
-0.11 (-1.18%)
At close · Oct 2
View the 10-K filed Feb 26, 2026
Return incl. dividend (before tax)
Customer concentration
— top 10 customers 24% of revenue
10 customers — 24% of revenue (the year ended December 31, 2025)
“Our ten largest customers accounted for 24% of revenues for the year ended December 31, 2025.”
Market Cap
$1.41B
Shares
152.54M
Volume · Oct 2
2.65M
Avg daily vol (3M)
3.17M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Faiz Mohammed | Interim Chief Financial Officer | Appointed | 2026-06-17 |
| John E. Gallagher III | Senior Vice President and Chief Financial Officer | Resigned | 2026-06-17 |
| Cynthia Collins | Class II director | Resigned | 2026-03-31 |
| Jon Resnick | Class III member of the Board | Appointed | 2025-12-11 |
| Jon Resnick | Chief Executive Officer | Appointed | 2025-12-11 |
| Dr. Patrick F. Smith | President, Certara Drug Development Solutions | Resigned | 2025-03-05 |
| Dr. John V. W. Reynders | Class II director | Appointed | 2024-10-16 |
| John E. Gallagher III | Chief Financial Officer | Appointed | 2023-03-01 |
| Mason Slaine | member of the Board of Directors | Resigned | 2022-12-23 |
| David Spaight | Class I director with a term expiring at the Company's 2024 Annual Meeting of Shareholders | Appointed | 2022-12-08 |
| Ethan Waxman | member of the Board of Directors | Resigned | 2022-12-08 |
| Eric Liu | member of the Board of Directors | Resigned | 2022-12-08 |
| David Spaight | Board | Appointed | 2022-11-07 |
| Ethan Waxman | Board | Resigned | 2022-11-07 |
| Eric Liu | Board | Resigned | 2022-11-07 |
| Justin Edge | President of Regulatory and Access | Resigned | 2022-08-12 |